Key result
Percutaneous closure of muscular and perimembranous ventricular septal defects achieves a 96% success rate with a major complication rate of around 2%.
Why the study?
Is percutaneous closure a safe and effective alternative to surgery for patients with ventricular septal defects?
Is percutaneous closure a safe and effective alternative to surgery for patients with ventricular septal defects?
Percutaneous closure of ventricular septal defects is a safe and effective alternative to surgery in selected patients, offering high success rates for congenital defects.
No takes yet. Share an insight, caveat, or question.
Supports percutaneous VSD closure in selected patients; leaves open need for randomized trials versus surgery.
Butera et al. (2007) conducted a review in Ventricular septal defects. Percutaneous closure vs. Standard surgical approach was evaluated on Successful closure of muscular and perimembranous defects. Percutaneous closure of muscular and perimembranous ventricular septal defects achieves a 96% success rate with a major complication rate of around 2%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: